Letter: Australia antigen in urine

Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.

European review for medical and pharmacological sciences·2015

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

The Journal of antimicrobial chemotherapy·2015

HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.

European review for medical and pharmacological sciences·2014

Tuberculosis: medico-legal aspects.

Mediterranean journal of hematology and infectious diseases·2014

Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2013

Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.

Infection·2012

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Marnetegragene Autotemcel: First Approval.

Molecular diagnosis & therapy·2026

Characterization of the complete mitochondrial genome and phylogenetic analysis of Amanita franzii (Amanitaceae, Agaricales).

Mitochondrial DNA. Part B, Resources·2026

Tunable Narrow-Linewidth Si3N4 External-Cavity Semiconductor Laser Based on an Asymmetric Bezier Triple-Ring Resonator.

Sensors (Basel, Switzerland)·2026

Nasal biopsy in ANCA-associated vasculitis: a game changer or a false friend?

Rhinology·2026

Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity.

Blood·2026

Early and late outcomes of surgical aortic valve replacement with or without aortic annular enlargement in patients with small aortic annulus: an exploratory comparison of Y-incision versus Manouguian techniques.

Journal of thoracic disease·2026

Related Experiment Videos

Letter: Australia antigen in urine

Related Concept Videos

Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.

HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.

HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.

Tuberculosis: medico-legal aspects.

Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver.

Hepatitis E virus and hepatitis A virus exposures in an apparently healthy high-risk population in Italy.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Marnetegragene Autotemcel: First Approval.

Characterization of the complete mitochondrial genome and phylogenetic analysis of <i>Amanita franzii</i> (Amanitaceae, Agaricales).

Tunable Narrow-Linewidth Si<sub>3</sub>N<sub>4</sub> External-Cavity Semiconductor Laser Based on an Asymmetric Bezier Triple-Ring Resonator.

Nasal biopsy in ANCA-associated vasculitis: a game changer or a false friend?

Factor VIII Aurora: A Naturally Occurring Gain of Function FVIII Variant with Enhanced FIXa Affinity.

Early and late outcomes of surgical aortic valve replacement with or without aortic annular enlargement in patients with small aortic annulus: an exploratory comparison of Y-incision versus Manouguian techniques.

Related Experiment Videos

Letter: Australia antigen in urine

Related Concept Videos

Related Articles